Alley Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-90,953
| Closed | -$5.57M | – | 81 |
|
|
2017
Q4 | $5.57M | Buy |
90,953
+4,413
| +5% | +$270K | 1.91% | 17 |
|
|
2017
Q3 | $5.52M | Buy |
86,540
+87
| +0.1% | +$5.55K | 2% | 17 |
|
|
2017
Q2 | $4.82M | Buy |
86,453
+1,557
| +2% | +$86.8K | 1.82% | 20 |
|
|
2017
Q1 | $4.62M | Buy |
84,896
+5,757
| +7% | +$313K | 1.82% | 22 |
|
|
2016
Q4 | $4.63M | Sell |
79,139
-1,621
| -2% | -$94.7K | 2.03% | 16 |
|
|
2016
Q3 | $4.36M | Buy |
80,760
+2,073
| +3% | +$112K | 1.94% | 17 |
|
|
2016
Q2 | $5.79M | Buy |
78,687
+1,634
| +2% | +$120K | 2.63% | 9 |
|
|
2016
Q1 | $4.92M | Buy |
77,053
+565
| +0.7% | +$36.1K | 2.36% | 10 |
|
|
2015
Q4 | $5.26M | Buy |
76,488
+1,100
| +1% | +$75.7K | 2.57% | 7 |
|
|
2015
Q3 | $4.46M | Buy |
75,388
+1,551
| +2% | +$91.8K | 2.3% | 10 |
|
|
2015
Q2 | $4.91M | Sell |
73,837
-461
| -0.6% | -$30.7K | 2.42% | 6 |
|
|
2015
Q1 | $4.79M | Buy |
74,298
+3,841
| +5% | +$248K | 2.35% | 5 |
|
|
2014
Q4 | $4.16M | Buy |
70,457
+4,109
| +6% | +$243K | 2.14% | 12 |
|
|
2014
Q3 | $3.4M | Buy |
66,348
+1,264
| +2% | +$64.7K | 2.45% | 9 |
|
|
2014
Q2 | $3.16M | Sell |
65,084
-3,435
| -5% | -$167K | 2.25% | 9 |
|
|
2014
Q1 | $3.56M | Buy |
68,519
+5,464
| +9% | +$284K | 2.51% | 6 |
|
|
2013
Q4 | $3.35M | Buy |
63,055
+21,057
| +50% | +$1.12M | 2.43% | 8 |
|
|
2013
Q3 | $1.94M | Buy |
41,998
+1,786
| +4% | +$82.7K | 1.55% | 29 |
|
|
2013
Q2 | $1.8M | Buy |
+40,212
| New | +$1.8M | 1.5% | 31 |
|